GlassScriptPhysician profile
Miranda D Willette
NPI 1578839593
$7,249.69
in general payments reported to CMS, 2019-2025
43 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,735 · 2022: $752 · 2023: $1,209 · 2024: $1,408 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,762.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,762.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,296.65 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $934.17 | 2021-2024 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $689.47 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $447.43 | 2021-2024 | Airsupra, Farxiga, Breztri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $275.76 | 2021-2024 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $262.47 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $243.55 | 2021-2024 | |
| Otsuka America Pharmaceutical, INC. | $242.46 | 2021-2024 | Rexulti |
| Esperion Therapeutics, INC. | $228.58 | 2021-2024 | Nexletol |
| Amarin Pharma, INC. | $220.37 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $216.02 | 2021-2024 | Jardiance, Synjardy |
| Merck Sharp & Dohme LLC | $207.46 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $192.78 | 2021-2023 | Xarelto |
| Exact Sciences Corporation | $154.43 | 2023-2024 | Cologuard Collection Kit |
| Amgen INC. | $140.63 | 2021-2023 | Repatha, Otezla |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miranda Willette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.